» Articles » PMID: 16530882

Modeling of Mesothelioma Growth Demonstrates Weaknesses of Current Response Criteria

Overview
Journal Lung Cancer
Specialty Oncology
Date 2006 Mar 15
PMID 16530882
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Applicability of the Response Evaluation Criteria in Solid Tumors (RECIST) to the geometry of mesothelioma has been recently investigated. A "modified RECIST" measurement technique developed for mesothelioma proposes measurement of tumor thickness rather than maximum diameter. This study evaluated the volumetric consistency of the RECIST response criteria as applied to the modified RECIST measurement technique. Geometric models were developed to simulate mesothelioma growth, and measurements of these models were calculated. Relationships between change in model measurements and corresponding change in model volume were derived and evaluated. Application of the RECIST response criteria to the typical spherical tumor model results in partial response (PR) classification based on a 66% volume decrease and progressive disease (PD) based on a 73% volume increase; for mesothelioma model thickness measurements, the RECIST criteria result in PR classification based on a 30% volume decrease and PD based on a 20% volume increase. Alternative response criteria for mesothelioma thickness measurement (-66% for PR, +74% for PD) achieve volumetric equivalence with the RECIST criteria for spherical tumor measurement. Application of the RECIST response criteria to mesothelioma thickness measurements yields PR and PD classifications based on smaller volume changes than for spherical tumors.

Citing Articles

Convolutional Neural Networks for Segmentation of Pleural Mesothelioma: Analysis of Probability Map Thresholds (CALGB 30901, Alliance).

Shenouda M, Gudmundsson E, Li F, Straus C, Kindler H, Dudek A J Imaging Inform Med. 2024; .

PMID: 39266911 DOI: 10.1007/s10278-024-01092-z.


Protocol for a prospective observational cohort study collecting data on demographics, symptoms and biomarkers in people with mesothelioma (ASSESS-meso).

Conway R, Symonds J, Walton D, Probets J, Comins C, Stadon L BMJ Open. 2022; 12(11):e060850.

PMID: 36357003 PMC: 9660577. DOI: 10.1136/bmjopen-2022-060850.


Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria.

Kidd A, Anderson O, Cowell G, Weir A, Voisey J, Evison M Thorax. 2022; 77(12):1251-1259.

PMID: 35110367 PMC: 9685726. DOI: 10.1136/thoraxjnl-2021-217808.


Deep learning-based segmentation of malignant pleural mesothelioma tumor on computed tomography scans: application to scans demonstrating pleural effusion.

Gudmundsson E, Straus C, Li F, Armato 3rd S J Med Imaging (Bellingham). 2020; 7(1):012705.

PMID: 32016133 PMC: 6987258. DOI: 10.1117/1.JMI.7.1.012705.


Deep convolutional neural networks for the automated segmentation of malignant pleural mesothelioma on computed tomography scans.

Gudmundsson E, Straus C, Armato 3rd S J Med Imaging (Bellingham). 2019; 5(3):034503.

PMID: 30840717 PMC: 6151316. DOI: 10.1117/1.JMI.5.3.034503.